Not conducted; in vitro IL-2-independent growth assay showed no transformation
“No carcinogenicity or tumorigenicity studies were conducted for bb2121. However, the applicant evaluated IL-2 independent growth in Study #10.”
✓ VerifiedFDA pharmacology/toxicology review, p. 27Source ↗